N, Growth kinetics of subcutaneous Capan-1 and Pa01C xenograft tumors treated as indicated when the tumor volume reached ∼100 mm 3. Ulixertinib, 100 mg/kg orally; ruxolitinib, 100 mg/kg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results